REAP Financial Group’s Heart Test Laboratories HSCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-380
Closed -$1.32K 576
2025
Q3
$1.32K Buy
+380
New +$1.38K ﹤0.01% 465

Other funds holding HSCS

REAP Financial Group's HSCS Position: Q4 2025 in Review

REAP Financial Group sold out of Heart Test Laboratories (HSCS) in Q4 2025, closing a stake of 380 shares — an estimated $1.32K sold.

REAP Financial Group first reported a position in HSCS in Q3 2025 and held it in 1 quarter. The position peaked at $1.32K in Q3 2025. 10 funds tracked by Wall St. Rank hold HSCS as of Q4 2025.

  • REAP Financial Group reported no remaining Heart Test Laboratories position as of Q4 2025 after selling out during the quarter.
  • REAP Financial Group sold 380 Heart Test Laboratories shares in Q4 2025, an estimated $1.32K.
  • REAP Financial Group first reported a position in Heart Test Laboratories in Q3 2025 and held it in 1 quarter.
  • REAP Financial Group's Heart Test Laboratories position peaked at $1.32K in Q3 2025.
  • 10 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q4 2025.

Based on REAP Financial Group's 13F filing for Q4 2025, filed 10 Feb 2026.